Submission Details
| 510(k) Number | K953875 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 28, 1995 |
| Decision Date | July 23, 1996 |
| Days to Decision | 391 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Statement |
K953875 is an FDA 510(k) clearance for the CRIT-LINE HEMATOCRIT ALERT (MODIFICATION), a System, Hemodialysis, Access Recirculation Monitoring (Class II — Special Controls, product code MQS), submitted by In-Line Diagnostics Corp. (Riverdale, US). The FDA issued a Cleared decision on July 23, 1996, 391 days after receiving the submission on June 28, 1995. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5820.
| 510(k) Number | K953875 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 28, 1995 |
| Decision Date | July 23, 1996 |
| Days to Decision | 391 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Statement |
| Product Code | MQS — System, Hemodialysis, Access Recirculation Monitoring |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 876.5820 |